Shares of leading medical devices company Danaher Corporation (NYSE:DHR) have advanced 27.5% in price over the past six months thanks to the company’s strategic collaborations and acquisitions to accelerate its growth. So, given the company’s solid fundamentals and sturdy growth attributes, can the stock maintain its rally? Let’s look at how our proprietary POWR Ratings system has assessed the stock. Read on.Danaher Corporation (DHR) is a Washington, D.C, -based multinational science and technology pioneer that develops, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its world-class brands hold leading positions in the demanding healthcare, environmental, and applied end markets.
The company's shares have gained 37.8% in price over the past year and 38.9% year-to-date to close yesterday’s trading session at $308.48. Its strong top-line growth, driven by improvements across all its business segments, and strategic acquisitions have driven its shares up this year.
We think DHR is well-positioned to continue gaining in the near term, relying on its solid fundamentals. Furthermore, its continuing efforts to expand its global reach and build a robust supply chain are expected to propel its performance in the coming months.